NAD+ Therapy: The Longevity Molecule Your Body Stops Making

What NAD+ Actually Does: The Four Pillars

1. DNA Repair via PARP Enzymes

Poly(ADP-ribose) polymerases — PARPs — are your body's primary DNA repair enzymes. Every time a strand breaks (thousands of times per day from UV radiation, oxidative stress, and normal metabolism), PARPs consume NAD+ to fix it. One study found that PARP1 alone accounts for 60-70% of cellular NAD+ consumption during DNA damage responses (Bai & Cantó, 2012, Cell Metabolism).

When NAD+ is depleted, PARPs cannot function. DNA damage accumulates. Mutations compound. Cancer risk increases. This is not theoretical — it is the mechanistic explanation for why cancer incidence rises exponentially with age.

2. Sirtuin Activation (The Longevity Genes)

Sirtuins (SIRT1-7) are a family of NAD+-dependent deacetylases that regulate virtually every aspect of cellular health: mitochondrial biogenesis, inflammation, fat metabolism, stress resistance, and epigenetic maintenance. They are sometimes called "longevity genes" because overexpression in model organisms consistently extends lifespan.

The critical point: sirtuins cannot function without NAD+. They do not merely use NAD+ as a cofactor — they consume it stoichiometrically. One deacetylation reaction = one NAD+ molecule destroyed. When NAD+ declines, sirtuin activity declines proportionally.

David Sinclair's lab at Harvard demonstrated that restoring NAD+ levels in aged mice reactivated SIRT1, improving mitochondrial function to levels resembling young animals within one week (Gomes et al., 2013, Cell).

3. Mitochondrial Energy Production

NAD+ (in its reduced form, NADH) is the primary electron carrier in oxidative phosphorylation — the process by which mitochondria generate ATP. Without adequate NAD+, the electron transport chain operates below capacity. Cells produce less energy. Fatigue, cognitive decline, and exercise intolerance follow.

The NAD+/NADH ratio also regulates which metabolic pathways are active. A high ratio favors oxidative metabolism (fat burning, efficient ATP production). A low ratio shifts cells toward glycolysis — less efficient and associated with chronic disease states.

4. Circadian Rhythm Regulation

SIRT1 directly deacetylates core clock proteins (BMAL1, PER2). NAD+ levels themselves oscillate in a circadian pattern, creating a metabolic clock that synchronizes with the light/dark cycle. When NAD+ is chronically low, circadian regulation breaks down — contributing to sleep disorders, metabolic syndrome, and accelerated aging (Nakahata et al., 2009, Cell).

---

The Bioavailability Debate: Injectable NAD+ vs. Oral Precursors

Oral NMN (Nicotinamide Mononucleotide)

NMN is a direct precursor to NAD+. Oral supplementation at 250-1000mg/day has shown modest increases in blood NAD+ levels in human trials (Yi et al., 2023, Science). However, NMN must survive gastric acid, cross the intestinal barrier, enter cells, and be enzymatically converted to NAD+. Bioavailability estimates range from 10-30%.

Oral NR (Nicotinamide Riboside)

NR follows a similar pathway. Tru Niagen and Elysium Basis are commercial products. Human trials show increased NAD+ metabolites in blood, but tissue-level increases — particularly in the brain and muscle — remain debated (Martens et al., 2018, Nature Communications).

IV NAD+ Infusions

IV NAD+ bypasses all absorption barriers and delivers the molecule directly to the bloodstream. Clinics across Canada charge $500-1000 per session, with protocols typically running 2-6 hours per infusion (the molecule causes intense nausea and chest tightness when infused too quickly). Effective but expensive and time-intensive.

Subcutaneous NAD+ Injection

This is the emerging middle path. Subcutaneous injection achieves near-complete bioavailability (estimated 85-95%) without the cost, time commitment, or clinical overhead of IV infusions. The molecule reaches systemic circulation within 15-30 minutes. Self-administration at home is straightforward with insulin syringes.

The key advantage over oral precursors: you are delivering NAD+ itself, not a precursor that requires enzymatic conversion. No rate-limiting enzymes. No intestinal degradation. No first-pass metabolism.

[Internal Link: /nad-plus-500mg/]

---

Protocol: Subcutaneous NAD+ Administration

Standard Protocol

Loading Phase (First 2 Weeks)

Many practitioners recommend a loading phase of daily injections at 200-300mg for 10-14 days, followed by a maintenance schedule of 2-3x weekly. This approach aims to rapidly replenish depleted cellular stores.

Dose Escalation

Start at 100mg to assess tolerance. NAD+ injection can cause a noticeable "flush" — warmth, tingling, mild chest pressure — that resolves within 5-10 minutes. Some users report injection site soreness lasting 30-60 minutes. These effects are dose-dependent and diminish with repeated administration.

Higher doses (500-1000mg) are used in anti-aging clinics for acute cognitive enhancement and recovery protocols. The upper limit of subcutaneous dosing in a single injection is typically 500mg due to volume constraints and comfort.

Cycling

NAD+ is not hormonal and does not suppress endogenous production. Long-term continuous use appears safe based on available data. Some users cycle 8 weeks on / 4 weeks off to manage cost, but there is no pharmacological rationale requiring cycling.

---

What to Expect: Timeline of Effects

Week 1

• Noticeable improvement in energy levels (reduced afternoon crashes)
• Clearer morning cognition
• Improved sleep onset (circadian rhythm normalization beginning)

Weeks 2-4

• Sustained mental clarity throughout the day
• Improved exercise recovery
• Reduced systemic inflammation markers (users report less joint stiffness)
• Skin quality improvements (collagen synthesis is NAD+-dependent)

Months 1-3

• Measurable reduction in biological age markers (if tracking via epigenetic clocks like TruAge or GlycanAge)
• Significant improvement in exercise capacity
• Stabilization of mood and stress resilience
• Potential improvement in metabolic markers (fasting glucose, insulin sensitivity)

Long-Term (6+ Months)

• Continued maintenance of youthful cellular function
• Cumulative benefits on DNA integrity and repair capacity
• Potential slowing of epigenetic aging (Sinclair's "information theory of aging" framework)

---

The David Sinclair Context

Harvard geneticist David Sinclair has been the most prominent scientific voice advocating NAD+ restoration as a longevity intervention. Key findings from his lab:

1. Aged mice rejuvenation: NMN supplementation reversed vascular aging in 20-month-old mice, restoring endurance capacity to levels of young animals (Das et al., 2018, Cell).

2. Information theory of aging: Sinclair proposes that aging is primarily a loss of epigenetic information, not genetic mutations. NAD+-dependent sirtuins maintain epigenetic marks. When NAD+ declines, epigenetic noise accumulates — and cells "forget" their identity (Sinclair, Lifespan, 2019).

3. Fertility restoration: NAD+ precursors restored oocyte quality and fertility in aged female mice (Bertoldo et al., 2020, Cell Reports).

4. COVID-19 connection: NAD+ depletion was identified as a factor in severe COVID outcomes, with PARP hyperactivation consuming NAD+ stores during the cytokine storm (Heer et al., 2020, Journal of Biological Chemistry).

While much of this work is in animal models, human trials are accelerating. The CALERIE study and several NMN/NR human trials have shown safety and biomarker improvements.

---

NAD+ vs. NMN vs. NR vs. Niacin: Comparison

The Precursor Bottleneck

The rate-limiting enzyme for NMN → NAD+ conversion is NMNAT (nicotinamide mononucleotide adenylyltransferase). The rate-limiting enzyme for NR → NMN is NRK (nicotinamide riboside kinase). Both enzymes decline with age — meaning the older you are (and the more you need NAD+), the less efficiently you convert precursors.

This is the core argument for injectable NAD+: you bypass every enzymatic bottleneck.

---

Side Effects and Safety Considerations

Common (Dose-Dependent)

• Injection site soreness: Mild to moderate, lasting 30-60 minutes. NAD+ solution has a low pH that can irritate tissue. Slower injection and site rotation minimize this.
• Flushing: Warmth, tingling, mild redness. More common at doses above 300mg. Resolves within 5-15 minutes.
• Chest tightness: A transient sensation at higher doses. Not cardiac in origin — related to autonomic nervous system activation. Resolves spontaneously.
• Nausea: Uncommon with subcutaneous administration (more associated with IV infusions given too rapidly).

Rare

• Headache: Occasionally reported in the first few sessions. May relate to increased cerebral blood flow.
• Insomnia: If injected too late in the day, the energizing effect may interfere with sleep. Morning administration prevents this.
• GI discomfort: Rare with subcutaneous route.

Contraindications

• Active cancer (NAD+ fuels all rapidly dividing cells, including tumors — PARP inhibitors are cancer drugs for this reason)
• Pregnancy/breastfeeding (insufficient safety data)
• Concurrent PARP inhibitor therapy

Lab Monitoring

No routine blood work is required for NAD+ supplementation. However, those interested in tracking efficacy can measure:

• Intracellular NAD+ levels (specialized labs like Jinfiniti)
• Epigenetic age testing (TruAge, GlycanAge)
• Inflammatory markers (hs-CRP, IL-6)

---

Stacking NAD+ With Other Longevity Compounds

NAD+ is non-hormonal and does not compete with receptors, making it universally stackable:

NAD+ + Resveratrol

Sinclair's own protocol includes resveratrol (a sirtuin activator) combined with NAD+ precursors. The logic: NAD+ provides the fuel; resveratrol acts as the accelerator pedal on SIRT1 specifically. Without adequate NAD+, resveratrol has limited substrate to work with. Without a sirtuin activator, NAD+ provides raw material but the enzymes operate at baseline capacity. Together, you fuel the engine and press the throttle.

Typical dose: Resveratrol 500-1000mg/day (taken with a fat source for absorption) alongside NAD+ injection protocol.

NAD+ + Metformin (The Controversy)

Metformin — the diabetes drug widely used off-label for longevity — activates AMPK and may support some of the same pathways as NAD+. However, Sinclair has noted that metformin may blunt exercise adaptations and potentially interfere with NMN's mitochondrial benefits. Some longevity practitioners alternate: metformin on rest days, NAD+ precursors on training days. The optimal interaction between these two interventions remains actively debated in the longevity research community.

NAD+ + Rapamycin

Rapamycin (mTOR inhibitor) addresses a different hallmark of aging — dysregulated nutrient sensing. NAD+ addresses mitochondrial dysfunction and genomic instability. Together, they target multiple aging hallmarks simultaneously without mechanistic conflict. The rapamycin community often includes NAD+ support as a baseline complement.

NAD+ + BPC-157

For recovery-focused protocols, BPC-157's tissue-healing properties complement NAD+'s cellular repair capacity. NAD+ supports DNA repair and mitochondrial function at the molecular level; BPC-157 accelerates macroscopic tissue healing. Users combining both report enhanced recovery from injury and surgery.

[Internal Link: /bpc-157/]

NAD+ + Peptide Anti-Aging Stacks

NAD+ pairs naturally with GH secretagogues (CJC-1295/Ipamorelin) for comprehensive anti-aging protocols. GH pulse provides anabolic recovery and tissue repair support; NAD+ provides the cellular energy infrastructure that makes repair possible. Epitalon (telomere support) is another common addition for those building comprehensive longevity stacks.

[Internal Link: /cjc-1295-ipamorelin/]

---

Who Should Consider NAD+ Therapy

Ideal Candidates

1. Adults over 35-40 experiencing age-related energy decline, cognitive fog, or exercise intolerance
2. Shift workers and travelers with disrupted circadian rhythms seeking metabolic resynchronization
3. Athletes over 30 noticing declining recovery capacity despite consistent training
4. Those with family history of neurodegenerative disease seeking neuroprotective intervention
5. Post-illness recovery (particularly post-viral fatigue syndromes where mitochondrial function is impaired)
6. Alcohol recovery — chronic alcohol consumption depletes NAD+ stores dramatically; restoration supports liver and neurological recovery
7. Longevity-focused biohackers tracking epigenetic age and biological markers

Less Ideal Candidates

1. Healthy individuals under 30 (NAD+ levels are naturally adequate)
2. Those unwilling to commit to injection protocols (oral precursors may be sufficient for mild support)
3. Active cancer patients (theoretical concern about fueling proliferating cells)
4. Those on very tight budgets (oral NMN may be a more cost-effective starting point)

---

Canadian Context

NAD+ is not a controlled substance in Canada. It is a naturally occurring coenzyme, not a pharmaceutical drug. Research-grade NAD+ for subcutaneous administration is available from Canadian peptide suppliers without a prescription.

IV NAD+ clinics operate in major Canadian cities (Toronto, Vancouver, Montreal, Calgary) at $500-1000 per session. Self-administered subcutaneous protocols offer the same molecule at a fraction of the cost — typically $150-400/month depending on dosing frequency.

Canadian winters, with their reduced sunlight exposure and vitamin D challenges, create additional NAD+ demands through sirtuin-mediated pathways. Some practitioners recommend higher NAD+ doses during winter months when circadian disruption is more common.

The Canadian longevity medicine community has grown significantly since 2023, with NAD+ clinics expanding from Vancouver and Toronto into secondary markets. Canadian-sourced NAD+ from domestic suppliers avoids cross-border customs delays that can compromise temperature-sensitive peptides during transit.

[Internal Link: /nad-plus-1000mg/]

---

Frequently Asked Questions

Can I combine NAD+ injections with oral NMN?

Yes. Some practitioners use a "belt and suspenders" approach: subcutaneous NAD+ 2-3x/week for direct replenishment, plus daily oral NMN (500-1000mg) for baseline support. There is no known interaction or redundancy concern — the NAD+ pool can absorb contributions from multiple sources.

How quickly will I feel a difference?

Most users report noticeable changes within 3-7 days of starting. Energy improvements and cognitive clarity are typically the first effects. Deeper benefits (inflammation reduction, metabolic improvements, sleep quality) develop over 2-6 weeks. Epigenetic age reversal, if it occurs, requires months of consistent use.

Is NAD+ the same as vitamin B3?

NAD+ is synthesized from vitamin B3 precursors (niacin, nicotinamide, NR, NMN), but it is not vitamin B3 itself. Calling NAD+ "vitamin B3" is like calling a house "lumber." B3 provides raw materials; NAD+ is the functional end product. You can take large amounts of B3 and still have inadequate NAD+ if conversion enzymes are impaired.

Do I need to cycle NAD+?

No pharmacological cycling is required. NAD+ does not suppress any endogenous production pathway, does not downregulate receptors, and does not create dependence. You can use it continuously. Some users cycle for cost management, but this is a financial decision, not a health one.

Can NAD+ reverse aging?

"Reverse" is a strong claim. What the evidence supports: NAD+ restoration can reverse specific biomarkers of aging (epigenetic age, vascular function, mitochondrial capacity, exercise tolerance) in both animal models and early human trials. Whether this translates to extended human lifespan remains unproven. What is more certain is that maintaining youthful NAD+ levels preserves cellular function and slows the accumulation of age-related damage.

---

Conclusion

NAD+ is not a supplement trend. It is a fundamental requirement of cellular life that declines predictably with age, taking your mitochondria, DNA repair machinery, and longevity gene activity down with it. The science connecting NAD+ depletion to aging is robust — published in Cell, Nature, Science, and supported by hundreds of mechanistic studies.

The practical question is delivery method. Oral precursors (NMN, NR) offer convenience but face bioavailability limitations and enzymatic bottlenecks that worsen with age. IV clinics offer direct delivery but at prohibitive cost and inconvenience. Subcutaneous NAD+ injection represents the rational middle path: near-complete bioavailability, self-administered at home, at a fraction of clinic pricing.

If you are over 35 and serious about longevity, NAD+ replenishment belongs in your protocol alongside exercise, sleep optimization, and metabolic health. The molecule is not optional — it is required for life. The only question is whether you will maintain adequate levels as you age or let them decline by default.

[Internal Link: /anti-aging-peptides/]

---

Disclaimer: This article is for educational and informational purposes only. It does not constitute medical advice. Consult a qualified healthcare provider before beginning any peptide or supplement protocol.